Posts

Posted on

FreightCar America, Inc. Announces Agreement to Redeem All Outstanding Preferred Shares with New Term Loan

New financing arrangement reduces Company’s cost of capital by approximately 40%

Further enhances financial flexibility, cash generation and ability to support growth strategy

CHICAGO, Jan. 06, 2025 (GLOBE NEWSWIRE) — FreightCar America, Inc. (NASDAQ: RAIL) (“FreightCar America” or the “Company”), a diversified manufacturer and supplier of railroad freight cars, railcar parts and components, today announced it has completed a new term loan facility. The proceeds from the term loan will be used to redeem all outstanding shares of Series C Preferred Stock, as well as settle all related accrued dividends.

Highlights:

  • The Company closed a $115 million 4-year term loan agreement on December 31st, 2024 (the “Term Loan”).
  • Proceeds from the Term Loan were used to redeem all 85,412 shares of Series C Preferred Stock that were outstanding and all accrued dividends as of December 31st, 2024.
  • The Term Loan is priced at SOFR + 600, which will reduce the Company’s existing cost of capital by approximately 40%, resulting in savings of approximately $9.2 million in the first year, or approximately $0.26 per share on a fully diluted basis.

Mike Riordan, Chief Financial Officer of FreightCar America, commented, “As further testament to the strength and momentum of FreightCar America, I am extremely pleased to announce that we have taken an important step to improve our capital structure and lower borrowing costs. The completion of this financing along with the retirement of our Series C Preferred Stock enhances our financial flexibility, cash flow generation and allows us to continue executing our growth strategy with even greater confidence and agility.”

For additional information about the Company’s update, please refer to the Company’s Form 8-K filed today with the Securities and Exchange Commission.

About FreightCar America

FreightCar America, headquartered in Chicago, Illinois, is a leading designer, producer and supplier of railroad freight cars, railcar parts and components. We also specialize in railcar repairs, complete railcar rebody services and railcar conversions that repurpose idled rail assets back into revenue service. Since 1901, our customers have trusted us to build quality railcars that are critical to economic growth and instrumental to the North American supply chain. To learn more about FreightCar America, visit www.freightcaramerica.com.

Investor Contact   [email protected] 



Posted on

Enterprise Financial Services Corp Announces Fourth Quarter 2024 Earnings Release and Conference Call

Enterprise Financial Services Corp Announces Fourth Quarter 2024 Earnings Release and Conference Call

ST. LOUIS–(BUSINESS WIRE)–
Enterprise Financial Services Corp (Nasdaq: EFSC) (“the Company” or “EFSC”) will release its fourth quarter 2024 financial results on Monday, January 27, 2025. The Company will host a conference call and webcast at 10:00 a.m. CT on Tuesday, January 28, 2025.

Participate by Dial-In

We encourage participants to pre-register for the conference call using the following link: https://bit.ly/EFSC4Q2024EarningsCallRegistration. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. The conference call will be accessible by telephone at 1-800-715-9871, after connecting you may say the name of the conference or enter the Conference ID 35973.

Participate by Webcast

The webcast will be accessible via the “Investor Relations” page of the Company’s website, https://investor.enterprisebank.com/events-and-presentations. The press release and related presentation slides will be accessible on the website prior to the scheduled call.

Participate by Replay

A recorded replay of the conference call will be available on the website, https://investor.enterprisebank.com/events-and-presentations after the call’s completion. The replay will be available for at least two weeks following the conference call.

Enterprise Financial Services Corp (Nasdaq: EFSC), with approximately $15.0 billion in assets, is a financial holding company headquartered in Clayton, Missouri. Enterprise Bank & Trust, a Missouri state-chartered trust company with banking powers and a wholly-owned subsidiary of EFSC, operates branch offices in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, and SBA loan and deposit production offices throughout the country. Enterprise Bank & Trust offers a range of business and personal banking services, and wealth management services. Enterprise Trust, a division of Enterprise Bank & Trust, provides financial planning, estate planning, investment management, and trust services to businesses, individuals, institutions, retirement plans and non-profit organizations. Additional information is available at www.enterprisebank.com.

Enterprise Financial Services Corp’s common stock is traded on the Nasdaq Stock Market under the symbol “EFSC.” Please visit our website at www.enterprisebank.com to see our regularly posted material information.

For Investor Relations Contact:

Keene Turner, Senior Executive Vice President and CFO (314) 512-7233

For Media Inquiries Contact:

Steve Richardson, Senior Vice President, Corporate Communications (314) 995-5695

KEYWORDS: Missouri United States North America

INDUSTRY KEYWORDS: Personal Finance Finance Banking Professional Services Asset Management

MEDIA:

Logo
Logo
Posted on

Sonder Holdings Inc. Appoints Erin Wallace to Board of Directors

Board Appoints Janice Sears as Independent Chair

SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) — Sonder Holdings Inc. (NASDAQ: SOND) (“Sonder” or the “Company”) today announced that Erin Wallace was appointed to its Board of Directors (the “Board”) on January 1, 2025. Nabeel Hyatt, who has served on the Sonder Board since 2016, resigned from the Board on December 31, 2024. Additionally, Sonder has transitioned to a structure with an independent director serving as the Board Chairperson, which is consistent with the Board’s focus on enhancing corporate governance. Janice Sears, who previously served as Lead Independent Director of the Board, has been appointed as Chairperson of the Board.

Ms. Wallace brings over three decades of operations expertise across the hospitality, entertainment and resort industries. She spent the majority of her career at The Walt Disney Company (“Disney”), where she held various senior executive roles across its theme parks and resorts business, including overseeing global guest-facing operations for all lines of business. Following her retirement from Disney, Ms. Wallace held subsequent executive roles as Chief Operating Officer of Great Wolf Resorts, Inc., where she led operations for the company’s entire lodge footprint across the U.S. and oversaw new lodge openings with next-generation brand standards and standard operating procedures, and as Chief Operating Officer of The Learning Care Group, Inc., where she led operations of over 900 early childhood education centers across the U.S. Ms. Wallace currently serves on the board of directors of FirstService Corporation and Coast Entertainment Holdings Limited.

Janice Sears, Chairperson of the Sonder Board, said, “We are thrilled to welcome Erin to the Sonder Board. Her expertise at the intersection of hospitality and operations is the perfect complement to our Board as we oversee Sonder’s next phase of transformation and growth. Ongoing refreshment and continuous governance enhancements are an important part of our work and the changes we announced today underscore that commitment. On behalf of the entire Board, I want to thank Nabeel for his countless contributions and longstanding service to Sonder.”

“As we continue to progress with our integration efforts under the strategic licensing agreement with Marriott International and with the continued execution of our operational initiatives across the business, Erin’s expertise will be immediately additive to the transformational efforts underway,” said Francis Davidson, Co-Founder and CEO of Sonder. “Nabeel saw our vision for Sonder from the very beginning and his early investment in our company has been a foundational part of our growth story. I have greatly appreciated his guidance as a Board member over the past decade and Nabeel has helped Sonder achieve numerous milestones.”


About Sonder

Sonder (NASDAQ: SOND) is a leading global brand of premium, design-forward apartments and intimate boutique hotels serving the modern traveler. Launched in 2014, Sonder offers inspiring, thoughtfully designed accommodations and innovative, tech-enabled service combined into one seamless experience. Sonder properties are found in prime locations in over 40 markets, spanning ten countries and three continents. The Sonder app gives guests full control over their stay. Complete with self-service features, simple check-in and 24/7 on-the-ground support, amenities and services at Sonder are just a tap away, making a world of better stays open to all.

To learn more, visit www.sonder.com or follow Sonder on Instagram, LinkedIn or X.

Download the Sonder app on Apple or Google Play.


Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are based upon current expectations or beliefs, as well as assumptions about future events. Forward-looking statements include all statements that are not historical facts and can generally be identified by terms such as “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potentially,” or “will” or similar expressions and the negatives of those terms. These statements include, but are not limited to, statements relating to the Company’s governance practices, strategy and operational initiatives, and the experience of Sonder’s Board and leadership team. Actual results could differ materially from those expressed in or implied by the forward-looking statements due to a number of risks and uncertainties, including the risks and uncertainties described in the Company’s SEC reports, and under the heading “Risk Factors” in its most recent annual report on Form 10-K and quarterly reports on Form 10-Q, which are available at www.sec.gov. The forward-looking statements contained herein are only as of the date of this press release. Except as required by law, the Company does not undertake any obligation to update or revise its forward-looking statements to reflect events or circumstances after the date of this press release.


Contacts

Media:
[email protected]

Investor:
[email protected]



Posted on

Helios Technologies Appoints Sean P. Bagan as President and Chief Executive Officer

Helios Technologies Appoints Sean P. Bagan as President and Chief Executive Officer

SARASOTA, Fla.–(BUSINESS WIRE)–Helios Technologies, Inc. (NYSE: HLIO) (“Helios” or the “Company”), a global leader in highly engineered motion control and electronic controls technology, today announced that its Board of Directors has promoted Sean P. Bagan to President and Chief Executive Officer, effective immediately. Mr. Bagan has also been nominated to the Company’s Board of Directors and will be eligible for election at the June 2025 Annual Meeting. The Board, through an external search firm, conducted a thorough search process consisting of internal and external candidates. Mr. Bagan has been serving as the Interim President, Chief Executive Officer and Chief Financial Officer since July 8, 2024. He will continue as Chief Financial Officer as Helios will now initiate a search to backfill Mr. Bagan’s previous role. In addition, Philippe Lemaitre will resume his role as Non-Executive Chairman.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250106056303/en/

(Photo: Business Wire)

(Photo: Business Wire)

“The Board has unanimously determined that Sean Bagan is the right choice to lead Helios Technologies into the future. He has done a great job in his Interim President and Chief Executive Officer position in addition to his Chief Financial Officer role over the last six months. He has confidently guided the operations as well as focused on new ways to further develop the high performing talent we have within the organization. We believe his passion for the business, his strategic mindset, his business acumen, his integrity, as well as his straightforward and service leadership style are exactly what Helios needs moving forward. We are very optimistic about Helios’ opportunities in 2025 and beyond. We thank Sean and the leadership team for their commitment during this transition period,” commented Philippe Lemaitre, Chairman of the Board.

“Helios Technologies is an exceptional organization, and I am deeply honored to be selected to lead its talented global team. Our customer centric focus is centered on combining a collection of engineered products and services allowing us to deliver leading technology solutions. I believe the Company with its deep history of innovation, is uniquely positioned to deliver compounded growth that drives shareholder value creation over time. I thank the Board for their continued confidence and support in both my team and me,” commented Sean Bagan, President, Chief Executive Officer and Chief Financial Officer.

About Sean Bagan

Sean Bagan has served as Chief Financial Officer of Helios since August 9, 2023 as well as Interim President and Chief Executive Officer effective July 8, 2024. Before joining Helios, Mr. Bagan spent 23 years at Polaris Inc., a global leader in powersports and off-road innovation. With extensive financial management leadership experience, Mr. Bagan brings more than 20 years of international business, strategic financial operations, and leadership experience. His responsibilities scaled with Polaris over the decades in operational finance, international sales, product segments, acquisitions and corporate finance and treasury. In addition to financial management positions, his roles included general management and operational oversight for U.S. and global businesses. He earned his B.A. double major in Accounting and Management from St. John’s University in Minnesota and began his career with Arthur Andersen, LLP. Mr. Bagan also holds a General Management Certificate from Cambridge University’s Judge Business School in England, along with a Certified Public Accountant (Inactive) Certificate from the state of Minnesota.

About Helios Technologies

Helios Technologies is a global leader in highly engineered motion control and electronic controls technology for diverse end markets, including construction, material handling, agriculture, energy, recreational vehicles, marine and health and wellness. Helios sells its products to customers in over 90 countries around the world. Its strategy for growth is to be the leading provider in niche markets, with premier products and solutions through innovative product development and acquisition. The Company has paid a cash dividend to its shareholders every quarter since becoming a public company in 1997. For more information please visit: www.heliostechnologies.com and follow us on LinkedIn.

FORWARD-LOOKING INFORMATION

This news release contains “forward‐looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward‐looking statements involve risks and uncertainties, and actual results may differ materially from those expressed or implied by such statements. They include statements regarding current expectations, estimates, forecasts, projections, our beliefs, and assumptions made by Helios Technologies, Inc. (“Helios” or the “Company”), its directors or its officers about the Company and the industry in which it operates, and assumptions made by management, and include among other items, (i) the Company’s strategies regarding growth and improved earnings power, including its intention to develop new products and make acquisitions; (ii) trends affecting the Company’s financial condition or results of operations; (iii) the Company’s ability to deliver predictable performance and margin expansion; (iv) the Company’s ability to leverage improvement in market conditions and expand market reach; and (v) the Company’s ability to embrace change and respond to changes in customer demand domestically and internationally, including as a result of the cyclical nature of our business and the standardization. In addition, we may make other written or oral statements, which constitute forward-looking statements, from time to time. Words such as “may,” “expects,” “projects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words, and similar expressions are intended to identify such forward-looking statements. Similarly, statements that describe our future plans, objectives or goals also are forward-looking statements. These statements are not guaranteeing future performance and are subject to a number of risks and uncertainties. Our actual results may differ materially from what is expressed or forecasted in such forward-looking statements, and undue reliance should not be placed on such statements. All forward-looking statements are made as of the date hereof, and we undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Factors that could cause the actual results to differ materially from what is expressed or forecasted in such forward‐looking statements include, but are not limited to, (i) the Company’s ability to respond to global economic trends and changes in customer demand domestically and internationally, including as a result of standardization and the cyclical nature of our business, which can adversely affect the demand for capital goods; (ii) supply chain disruption and the potential inability to procure goods; (iii) conditions in the capital markets, including the interest rate environment and the availability of capital on terms acceptable to us, or at all; (iv) global and regional economic and political conditions, including inflation (or hyperinflation) exchange rates, changes in the cost or availability of energy, transportation, the availability of other necessary supplies and services and recession; (v) changes in the competitive marketplace that could affect the Company’s revenue and/or cost bases, such as increased competition, lack of qualified engineering, marketing, management or other personnel, and increased labor and raw materials costs; (vi) risks related to health epidemics, pandemics and similar outbreaks, which may among other things, adversely affect our supply chain, material costs, and work force and may have material adverse effects on our business, financial position, results of operations and/or cash flows; (vii) risks related to our international operations, including the potential impact of the ongoing conflict in Ukraine and the Middle East; (viii) new product introductions, product sales mix and the geographic mix of sales nationally and internationally; and (ix) stakeholders, including regulators, views regarding our environmental, social and governance goals and initiatives, and the impact of factors outside of our control on such goals and initiatives. Further information relating to additional factors that could cause actual results to differ from those anticipated is included but not limited to information under the heading Item 1. “Business” and Item 1A. “Risk Factors” in the Company’s Form 10-K for the year ended December 30, 2023 filed with the Securities and Exchange Commission (SEC) on February 27, 2024 as well as any subsequent filings with the SEC.

Investor and Media contacts:

Tania Almond

Vice President, Investor Relations and Corporate Communication

(941) 362-1333

[email protected]


Deborah Pawlowski

Alliance Advisors IR

(716) 843-3908

[email protected]

KEYWORDS: Florida United States North America

INDUSTRY KEYWORDS: Other Manufacturing Technology Automotive General Automotive Engineering Automotive Manufacturing Manufacturing Other Automotive Electronic Design Automation

MEDIA:

Logo
Logo
Photo
Photo
(Photo: Business Wire)
Posted on

Mercury Systems Announces Board of Directors Update

Roger Krone, former Chairman and CEO of Leidos, departs Board to focus on Boy Scouts of America

Jean Bua, CFO of NetScout Systems, appointed to Board

ANDOVER, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical processing power to the edge, announced the departure of Roger Krone from its Board of Directors and the appointment of new Independent Director Jean Bua.

Since joining Mercury’s Board of Directors, Mr. Krone has been appointed as President and Chief Executive Officer of the Boy Scouts of America and is planning to focus his time on the Boy Scouts and other business matters. Bill Ballhaus, Mercury Systems Chairman and CEO said, “We thank Roger for his service on the Board and wish him the best in his leadership of the Boy Scouts of America.”

Jean Bua is the Chief Financial Officer of NetScout Systems Inc., a publicly traded network performance and cybersecurity solutions company. Ms. Bua has decades of financial and accounting experience and will serve on the Audit and Government Relations Committees of the Board. Bill Ballhaus continued, “We are excited to have Jean join the Board. Jean’s appointment brings immense financial, accounting, governance, and compliance leadership in a relevant industry to the boardroom, along with strategic insight and risk management experience.”

About Jean Bua

Jean Bua has served as the Chief Financial Officer at NetScout Systems Inc., a publicly traded network performance and cybersecurity solutions company, since 2011. Jean brings over 40 years of financial, accounting, audit, operational, and business experience and a passion for technological transformation. She joined NetScout from American Tower, where she served as Executive Vice President of Finance and Treasurer and previously as the Senior Vice President and Corporate Controller. She also held roles as Controller at several former companies, including Iron Mountain, Inc., and Duracraft, was a management consultant at Ernst & Young and an Auditor at KPMG. Jean has served as an Independent Director on several publicly traded company boards. Jean received an M.B.A. from the University of Rhode Island and a B.S. in accounting from Bryant University.

Mercury Systems – Innovation that matters®

Mercury Systems is a technology company that delivers mission-critical processing power to the edge, making advanced technologies profoundly more accessible for today’s most challenging aerospace and defense missions. The Mercury Processing Platform allows customers to tap into innovative capabilities from silicon to system scale, turning data into decisions on timelines that matter. Mercury’s products and solutions are deployed in more than 300 programs and across 35 countries, enabling a broad range of applications in mission computing, sensor processing, command and control, and communications. Mercury is headquartered in Andover, Massachusetts, and has 23 locations worldwide. To learn more, visit mrcy.com. (Nasdaq: MRCY)

Forward-Looking Safe Harbor Statement

This press release contains certain forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, including those relating to the Company’s focus on enhanced execution of the Company’s strategic plan under a refreshed Board and leadership team. You can identify these statements by the words “may,” “will,” “could,” “should,” “would,” “plans,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” “likely,” “forecast,” “probable,” “potential,” and similar expressions. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. Such risks and uncertainties include, but are not limited to, continued funding of defense programs, the timing and amounts of such funding, general economic and business conditions, including unforeseen weakness in the Company’s markets, effects of any U.S. federal government shutdown or extended continuing resolution, effects of geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in or cost increases related to completing development, engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, changes in, or in the U.S. government’s interpretation of, federal export control or procurement rules and regulations, changes in, or in the interpretation or enforcement of, environmental rules and regulations, market acceptance of the Company’s products, shortages in or delays in receiving components, supply chain delays or volatility for critical components, production delays or unanticipated expenses including due to quality issues or manufacturing execution issues, adherence to required manufacturing standards, capacity underutilization, increases in scrap or inventory write-offs, failure to achieve or maintain manufacturing quality certifications, such as AS9100, the impact of supply chain disruption, inflation and labor shortages, among other things, on program execution and the resulting effect on customer satisfaction, inability to fully realize the expected benefits from acquisitions, restructurings, and operational efficiency initiatives or delays in realizing such benefits, challenges in integrating acquired businesses and achieving anticipated synergies, effects of shareholder activism, increases in interest rates, changes to industrial security and cyber-security regulations and requirements and impacts from any cyber or insider threat events, changes in tax rates or tax regulations, such as the deductibility of internal research and development, changes to interest rate swaps or other cash flow hedging arrangements, changes to generally accepted accounting principles, difficulties in retaining key employees and customers, litigation, including the dispute arising with the former CEO over his resignation, unanticipated costs under fixed-price service and system integration engagements, and various other factors beyond our control. These risks and uncertainties also include such additional risk factors as are discussed in the Company’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended June 28, 2024 and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to update any forward looking statement to reflect events or circumstances after the date on which such statement is made.

INVESTOR CONTACT

David Williams
Mercury Investor Relations
[email protected]

MEDIA CONTACT

Turner Brinton
Senior Director, Corporate Communications
[email protected]



Posted on

Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Wilmington, DE, Jan. 06, 2025 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors at the 43nd Annual J.P. Morgan Healthcare Conference with a presentation scheduled for Monday, January 13th, 2025, at 9:45 a.m. PST (12:45 p.m. EST). A link to the live audio webcast, as well as a copy of the accompanying presentation slides and a replay of this event, will be available on the company’s website (www.enovis.com) at Events and Presentations.      


ABOUT ENOVIS

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.  For more information about Enovis, please visit www.enovis.com.


Contact:

Kyle Rose
Vice President, Investor Relations
Enovis Corporation
[email protected]



Posted on

ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Jacob M. Chacko, M.D., chief executive officer, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 11:15 a.m. PT.

A live webcast of the company presentation will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days following the event.

About ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-114, a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers, and (2) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer. Beyond these two product candidates, ORIC® is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.

Contact:

Dominic Piscitelli, Chief Financial Officer
[email protected]
[email protected]



Posted on

UGI Corporation to Hold Fiscal 2025 First Quarter Earnings Conference Call on Thursday, February 6

UGI Corporation to Hold Fiscal 2025 First Quarter Earnings Conference Call on Thursday, February 6

VALLEY FORGE, Pa.–(BUSINESS WIRE)–
UGI Corporation (NYSE: UGI) will announce its Fiscal 2025 first quarter results after the market closes on February 5, 2025. The company will hold a live internet audio webcast of its conference call to discuss these results at 9:00 AM ET on Thursday, February 6.

Interested parties may listen to the audio webcast both live and in replay on the Internet at https://www.ugicorp.com/investors/financial-reports/events-and-presentations or by visiting the company website https://www.ugicorp.com and clicking on “Investors” and then “Events and Presentations.”

About UGI

UGI Corporation (NYSE: UGI) is a distributor and marketer of energy products and services in the U.S. and Europe. UGI offers safe, reliable, affordable, and sustainable energy solutions to customers through its subsidiaries, which provide natural gas transmission and distribution, electric generation and distribution, midstream services, propane distribution, renewable natural gas generation, distribution and marketing, and energy marketing services.

Comprehensive information about UGI Corporation is available on the Internet at https://www.ugicorp.com.

INVESTOR RELATIONS

610-337-1000

Tameka Morris, ext. 6297

Arnab Mukherjee, ext. 7498

KEYWORDS: Pennsylvania United States North America

INDUSTRY KEYWORDS: Rail Utilities Logistics/Supply Chain Management Oil/Gas Transport Alternative Energy Energy

MEDIA:

Logo
Logo
Posted on

Omega Announces Key Leadership Changes

Omega Announces Key Leadership Changes

HUNT VALLEY, Md.–(BUSINESS WIRE)–
Omega Healthcare Investors, Inc. (NYSE:OHI) (the “Company” or “Omega”) today announced key leadership changes. Matthew Gourmand, previously Senior Vice President, Corporate Strategy & Investor Relations, has been appointed President, and Vikas Gupta, previously Senior Vice President, Acquisitions & Development, has been appointed Chief Investment Officer. Separately, after 23 years as Chief Operating Officer, Dan Booth has stepped down from his position and is expected to remain in a consulting role for a period of 12 months.

Taylor Pickett, Omega’s Chief Executive Officer, stated, “The Company has been fortunate to enjoy a stable executive team for many years, while augmenting the long-standing team with the next generation of leaders. The announcement today marks the next stage of the Company’s long-term and continuous succession planning process.” Mr. Pickett continued, “Having worked with Matthew and Vikas since they joined the team, I believe their significant industry experience, strong business acumen, and exceptional work ethic will help drive the next stage of growth at the company.” Mr. Pickett concluded, “Dan Booth has been an integral member of the Omega team for over 23 years. His contributions to our success have been extensive, and, on behalf of the entire Company, I want to thank Dan for the critical role he has played in shaping Omega.”

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK. More information on Omega is available at www.omegahealthcare.com.

Andrew Dorsey, VP, Corporate Strategy & Investor Relations, or

David Griffin, Director, Corporate Strategy & Investor Relations, at (410) 427-1705

KEYWORDS: Maryland United States North America

INDUSTRY KEYWORDS: Nursing Health Managed Care Construction & Property General Health REIT

MEDIA:

Logo
Logo
Posted on

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

CHICAGO–(BUSINESS WIRE)–
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on January 2, 2025, the Compensation Committee of Xeris’ Board of Directors granted restricted stock units for an aggregate of 181,500 shares of its common stock to 19 new employee(s) under Xeris’ Inducement Equity Plan.

Xeris’ Inducement Equity Plan is used exclusively for the grant of equity awards to individuals who were not previously employed by Xeris or one of its subsidiaries as an inducement material to such individual’s entering into employment with Xeris or one of its subsidiaries, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules. The restricted stock units will vest over a period of three years in equal annual installments and are subject to the employees’ continued employment with Xeris or one of its subsidiaries. All equity awards are subject to the terms and conditions of Xeris’ Inducement Equity Plan and forms of award agreements covering the grants.

About Xeris

Xeris (Nasdaq: XERS) is a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies. Xeris has three commercially available products: Recorlev®, for the treatment of endogenous Cushing’s syndrome; Gvoke®, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis®, a proven therapy for primary periodic paralysis. Xeris also has a pipeline of development programs led by XP-8121, a Phase 3-ready, once-weekly subcutaneous injection of levothyroxine for hypothyroidism as well as multiple early-stage programs leveraging Xeris’ technology platforms, XeriSol® and XeriJect®, for its partners.

Xeris Biopharma Holdings is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow us on X, LinkedIn, or Instagram.

Allison Wey

Senior Vice President, Investor Relations and Corporate Communications

[email protected]

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health

MEDIA:

Logo
Logo